Clinical Lot Consistency for RSVpreF in a Population of Healthy Adults 18 to ≤49 Years of Age
Clinical trial NCT05096208 · COMPLETED
Trial details
- NCT number
- NCT05096208
- Sponsor
- Pfizer
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2021-10-21
- Primary completion
- 2022-04-04
- Enrollment
- 1028
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.